The role of complement and activated microglia in the pathogenesis of Alzheimer's disease
The DOI matches its Crossref record; 97 of the 100 references it cites were found in a registry or an index.
Abstract
A variety of inflammatory mediators including complement activation products, protease inhibitors, and cytokines are colocalized with beta-amyloid (A beta) deposits in the Alzeimer's disease (AD) brain. Activation products of the early complement components C1, C4, and C3 are always found in neuritic plaques and to a lesser extent in varying numbers of diffuse plaques. In contrast to these findings, no immunohistochemical evidence was obtained for the presence of the late complement components C7 and C9 and the complement membrane attack complex in the neuropathological lesions in AD brains. The mRNA encoding the late complement components C7 and C9 appears to be hardly or not detectable. These findings indicate that in AD the complement system does not act as an inflammatory mediator through membrane attack complex formation, but through the actions of the early complement products. In this review we focus on the role of complement in the pathological amyloid cascade in AD. In our opinion, the early complement activation products play a crucial role as mediators between the A beta deposits and the inflammatory responses leading to neurotoxicity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Complement can recruit and activate microglia around fibrillar Aβ deposits (19) and mediates, in part, the uptake and clearance of Aβ by the interaction of complement component iC3b with its receptor CR3 (CD11b/CD18) on the surface of microglia (20).”
From Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP/PS1 mice (2017) · cites this paper as [19]
Citations
Cites
Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1977 · Cited by 4,268
The molecular pathology of Alzheimer's disease
Selkoe, D. J. (1991) · Neuron · doi:10.1016/0896-6273(91)90052-2 · Cited by 2,708
Amyloid deposition as the central event in the aetiology of Alzheimer’s disease
Hardy, J., & Allsop, D. (1991) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(91)90609-v · Cited by 2,538
Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.
Griffin, W. S., Stanley, L. C., Ling, C., White, L., MacLeod, V, Perrot, L. J., White, C. L., & Araoz, C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.19.7611 · Cited by 1,777
Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state
Pike, C., Burdick, D., Walencewicz, A., Glabe, C., & Cotman, C. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-04-01676.1993 · Cited by 1,417
Abraham, C. R., Selkoe, D. J., & Potter, H. (1988) · Cell · doi:10.1016/0092-8674(88)90462-x · Cited by 900
Ma, J., Yee, A., Brewer, H. B., Das, S., & Potter, H. (1994) · Nature · doi:10.1038/372092a0 · Cited by 871
McGeer, P. L., Itagaki, S., Tago, H., & McGeer, E. G. (1987) · Neuroscience Letters · doi:10.1016/0304-3940(87)90696-3 · Cited by 836
Dickson, D. W., Lee, S. C., Mattiace, L. A., Yen, S. C., & Brosnan, C. (1993) · Glia · doi:10.1002/glia.440070113 · Cited by 825
Complement activation by beta-amyloid in Alzheimer disease.
Rogers, J., Cooper, N. R., Webster, S., Schultz, J., McGeer, P. L., Styren, S. D., Civin, W. H., Brachova, L., Bradt, B., & Ward, P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10016 · Cited by 817
Rogers, J., Luber-Narod, J., Styren, S. D., & Civin, W. H. (1988) · Neurobiology of Aging · doi:10.1016/s0197-4580(88)80079-4 · Cited by 743
Production of superoxide anions by a CNS macrophage, the microglia
Colton, C. A., & Gilbert, D. L. (1987) · FEBS Letters · doi:10.1016/0014-5793(87)80305-8 · Cited by 614
Regional pattern of degeneration in Alzheimer's disease: neuronal loss and histopathological grading
BRUN, A., & ENGLUND, E. (1981) · Histopathology · doi:10.1111/j.1365-2559.1981.tb01818.x · Cited by 561
T. Griffin, W. S., Sheng, J. G., Roberts, G. W., & Mrak, R. E. (1995) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199503000-00014 · Cited by 549
Structure and Biological Role of Vitronectin
Preissner, K. T. (1991) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.07.110191.001423 · Cited by 486
Interleukin‐6 and α‐2‐macroglobulin indicate an acute‐phase state in Alzheimer's disease cortices
Bauer, J., Strauss, S., Schreiter-Gasser, U., Ganter, U., Schlegel, P., Witt, I., Yolk, B., & Berger, M. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)80737-n · Cited by 483
Structure of pentameric human serum amyloid P component
Emsley, J., White, H. E., O'Hara, B. P., Oliva, G., Srinivasan, N., Tickle, I. J., Blundell, T. L., Pepys, M. B., & Wood, S. P. (1994) · Nature · doi:10.1038/367338a0 · Cited by 464
Immune System Response in Alzheimer's Disease
McGeer, P. L., Akiyama, H., Itagaki, S., & McGeer, E. G. (1989) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100029863 · Cited by 459
Immunoglobulins and complement factors in senile plaques: An immunoperoxidase study
Eikelenboom, P., & Stam, F. C. (1982) · Acta Neuropathologica · doi:10.1007/bf00685397 · Cited by 454
Self-citationJiang, H., Burdick, D., Glabe, C. G., Cotman, C. W., & Tenner, A. J. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.10.5050 · Cited by 330
Ghiso, J., Matsubara, E., Koudinov, A., Choi-Miura, N. H., Tomita, M., Wisniewski, T., & Frangione, B. (1993) · Biochemical Journal · doi:10.1042/bj2930027 · Cited by 304
Snow, A. D., Sekiguchi, R., Nochlin, D., Fraser, P., Kimata, K., Mizutani, A., Arai, M., Schreier, W. A., & Morgan, D. G. (1994) · Neuron · doi:10.1016/0896-6273(94)90165-1 · Cited by 299
Inflammatory mechanisms in Alzheimer's disease
Eikelenboom, P., Zhan, S.-S., van Gool, W. A., & Allsop, D. (1994) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(94)90057-4 · Cited by 291
Self-citationComplement activation in amyloid plaques in Alzheimer’s dementia
Eikelenboom, P., Hack, C. E., Rozemuller, J. M., & Stam, F. C. (1988) · Virchows Archiv B Cell Pathology Including Molecular Pathology · doi:10.1007/bf02890024 · Cited by 288
Self-citationYamaguchi, H., Hirai, S., Morimatsu, M., Shoji, M., & Ihara, Y. (1988) · Acta Neuropathologica · doi:10.1007/bf00689591 · Cited by 283
HYMAN, B. T., MARZLOFF, K., & ARRIAGADA, P. V. (1993) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199311000-00006 · Cited by 276
Tagliavini, F., Giaccone, G., Frangione, B., & Bugiani, O. (1988) · Neuroscience Letters · doi:10.1016/0304-3940(88)90080-8 · Cited by 271
Wright, S. D., Craigmyle, L. S., & Silverstein, S. C. (1983) · The Journal of experimental medicine · doi:10.1084/jem.158.4.1338 · Cited by 270
Vandenabeele, P., & Fiers, W. (1991) · Immunology Today · doi:10.1016/0167-5699(91)90032-o · Cited by 264
Ogomori, K., Kitamoto, T., Tateishi, J., Sato, Y., Suetsugu, M., & Abe, M. (1989) · Europe PMC (PubMed Central) · Cited by 245
Rozemuller, J. M., Eikelenboom, P., Stam, F. C., Beyreuther, K., & Masters, C. L. (1989) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-198911000-00009 · Cited by 243
Self-citationDistribution of clusterin in Alzheimer brain tissue
McGeer, P. L., Kawamata, T., & Walker, D. G. (1992) · Brain Research · doi:10.1016/0006-8993(92)90071-g · Cited by 212
Lacy, M., Jones, J., Whittemore, S. R., Haviland, D. L., Wetsel, R. A., & Barnum, S. R. (1995) · Journal of Neuroimmunology · doi:10.1016/0165-5728(95)00075-d · Cited by 200
Johnson, S. A., Lampert-Etchells, M., Pasinetti, G. M., Rozovsky, I., & Finch, C. E. (1992) · Neurobiology of Aging · doi:10.1016/0197-4580(92)90086-d · Cited by 177
Dela�re, P., Duyckaerts, C., He, Y., Piette, F., & Hauw, J. J. (1991) · Acta Neuropathologica · doi:10.1007/bf00305876 · Cited by 175
Rozemuller, J. M., Eikelenboom, P., Pals, S. T., & Stam, F. C. (1989) · Neuroscience Letters · doi:10.1016/0304-3940(89)90547-8 · Cited by 173
Self-citationImmuno-electron-microscopic localization of complements in amyloid fibrils of senile plaques
Ishii, T., & Haga, S. (1984) · Acta Neuropathologica · doi:10.1007/bf00687336 · Cited by 172
Sulfated glycoprotein 2: new relationships of this multifunctional protein to neurodegeneration
May, P. C., & Finch, C. E. (1992) · Trends in Neurosciences · doi:10.1016/0166-2236(92)90190-j · Cited by 170
Complement gene expression in human brain: comparison between normal and Alzheimer disease cases
Walker, D. G., & McGeer, P. L. (1992) · Molecular Brain Research · doi:10.1016/0169-328x(92)90017-6 · Cited by 167
Active Disassembly of the First Complement Component, C1̄, by C1̄ Inactivator
Ziccardi, R. J., & Cooper, N. R. (1979) · The Journal of Immunology · doi:10.4049/jimmunol.123.2.788 · Cited by 159
Snow, A. D., Sekiguchi, R., Nochlin, D., Kalaria, R. N., & Kimata, K. (1994) · PubMed Central · Cited by 153
Astrocytes in Alzheimer's disease gray matter express alpha 1-antichymotrypsin mRNA.
Pasternack, J. M., Abraham, C. R., Dyke, B. J. V., Potter, H., & Younkin, S. G. (1989) · PubMed Central · Cited by 152
Mann, D. M. A., Jones, D., Prinja, D., & Purkiss, M. (1990) · Acta Neuropathologica · doi:10.1007/bf00294651 · Cited by 152
Haga, S., Ikeda, K., Sato, M., & Ishii, T. (1993) · Brain Research · doi:10.1016/0006-8993(93)91698-r · Cited by 146
Fraser, P. E., Nguyen, J. T., McLachlan, D. R., Abraham, C. R., & Kirschner, D. A. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03568.x · Cited by 139
Complement C1qB and C4 mRNAs responses to lesioning in rat brain
Pasinetti, G. M., Johnson, S. A., Rozovsky, I., Lampert-Etchells, M., Morgan, D., Gordon, M. N., Morgan, T. E., Willoughby, D., & Finch, C. E. (1992) · Experimental Neurology · doi:10.1016/0014-4886(92)90028-o · Cited by 138
Alpha 1-antichymotrypsin regulates Alzheimer beta-amyloid peptide fibril formation.
Eriksson, S., Janciauskiene, S., & Lannfelt, L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.6.2313 · Cited by 138
Expression of intercellular adhesion molecule 1 (ICAM-1) in Alzheimer’s disease
Frohman, E. M., Frohman, T. C., Gupta, S., de Fougerolles, A., & van den Noort, S. (1991) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(91)90202-i · Cited by 120
Akiyama, H., Kawamata, T., Dedhar, S., & McGeer, P. L. (1991) · Journal of Neuroimmunology · doi:10.1016/0165-5728(91)90067-h · Cited by 120
Itagaki, S., Akiyama, H., Saito, H., & McGeer, P. L. (1994) · Brain Research · doi:10.1016/0006-8993(94)91640-3 · Cited by 119
Gasque, P., Ischenko, A., Legoedec, J., Mauger, C., Schouft, M. T., & Fontaine, M. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74572-4 · Cited by 117
Amyloid β-protein precursor: new clues to the genesis of Alzheimer's disease
Selkoe, D. J. (1994) · Current Opinion in Neurobiology · doi:10.1016/0959-4388(94)90014-0 · Cited by 117
The participation of interleukin-6 in the pathogenesis of alzheimer's disease
Bauer, J., Ganter, U., Strauss, S., Stadtmüller, G., Frommberger, U., Bauer, H. C., Volk, B., & Berger, T. (1992) · Research in Immunology · doi:10.1016/0923-2494(92)80051-l · Cited by 110
Detection of the membrane inhibitor of reactive lysis (CD59) in diseased neurons of Alzheimer brain
McGeer, P. L., Walker, D. G., Akiyama, H., Kawamata, T., Guan, A. L., Parker, C. J., Okada, N., & McGeer, E. G. (1991) · Brain Research · doi:10.1016/0006-8993(91)90071-3 · Cited by 107
(1994) · PubMed Central · Cited by 105
Complement C1 inhibitor is produced by brain tissue and is cleaved in Alzheimer disease
Walker, D. G., Yasuhara, O., Patston, P. A., McGeer, E. G., & McGeer, P. L. (1995) · Brain Research · doi:10.1016/0006-8993(95)00041-n · Cited by 100
Rozemüller, A. J. M., Abbink, J. J., Kamp, A. M., Stam, F. C., Hack, C. E., & Eikelenboom, P. (1991) · Acta Neuropathologica · doi:10.1007/bf00294446 · Cited by 99
Self-citationRozemüller, A. J. M., Stam, F. C., & Eikelenboom, P. (1990) · Neuroscience Letters · doi:10.1016/0304-3940(90)90759-3 · Cited by 98
Self-citationComplement activation and β-amyloid-mediated neurotoxicity in Alzheimer's disease
Rogers, J., Schultz, J., Brachova, L., Lue, L. F., Webster, S. M., Bradt, B. M., Cooper, N. R., & Moss, D. E. (1992) · Research in Immunology · doi:10.1016/0923-2494(92)80046-n · Cited by 90
Väkevä, A., Laurila, P., & Meri, S. (1992) · PubMed · Cited by 90
Van Muiswinkel, F. L., Veerhuis, R., & Eikelenboom, P. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66062468.x · Cited by 85
Self-citationVeerhuis, R., van der Valk, P., Janssen, I., Zhan, S., Eikelenboom, P., & Nostrand, W. E. V. (1995) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf00192116 · Cited by 83
Self-citationEikelenboom, P., Zhan, S., Kamphorst, W., van der Valk, P., & Rozemüller, A. J. M. (1994) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf00190565 · Cited by 83
Self-citationEnhanced aggregation and β structure of amyloid β peptide after coincubation with C1Q
Webster, S., O'Barr, S., & Rogers, J. (1994) · Journal of Neuroscience Research · doi:10.1002/jnr.490390412 · Cited by 81
Eikelenboom, P., Rozemüller, A. J. M., Kraal, G., Stam, F. C., McBride, P., Bruce, M. E., & Fraser, H. (1991) · Virchows Archiv B Cell Pathology Including Molecular Pathology · doi:10.1007/bf02899564 · Cited by 81
Self-citationZhan, S., Veerhuis, R., Kamphorst, W., & Eikelenboom, P. (1995) · Neurodegeneration · doi:10.1016/1055-8330(95)90018-7 · Cited by 79
Self-citationEarly complement components in Alzheimer's disease brains
Veerhuis, R., Janssen, I., Hack, C. E., & Eikelenboom, P. (1995) · Acta Neuropathologica · doi:10.1007/s004019570001 · Cited by 77
Self-citationNonimmune activation of the classical complement pathway.
Gewurz, H., Ying, S.-C., Jiang, H., & Lint, T. F. (1993) · PubMed · Cited by 75
The Immunopathology of Alzheimer's Disease and Some Related Disorders
Kalaria, R. N. (1993) · Brain Pathology · doi:10.1111/j.1750-3639.1993.tb00761.x · Cited by 69
Bobak, D. A., Frank, M. M., & Tenner, A. J. (1988) · European Journal of Immunology · doi:10.1002/eji.1830181220 · Cited by 64
Rozemüller, A. J. M., Eikelenboom, P., Kamphorst, W., & Stam, F. C. (1988) · Neurobiology of Aging · doi:10.1016/s0197-4580(88)80085-x · Cited by 63
Self-citationComplement proteins and complement inhibitors in Alzheimer's disease
McGeer, P. L., & McGeer, E. G. (1992) · Research in Immunology · doi:10.1016/0923-2494(92)80045-m · Cited by 57
Korotzer, A. R., Watt, J. A., Cribbs, D. H., Tenner, A. J., Burdick, D., Glabe, C. G., & Cotman, C. W. (1995) · Experimental Neurology · doi:10.1006/exnr.1995.1051 · Cited by 54
Smyth, M. D., Cribbs, D. H., Tenner, A. J., Shankle, W. R., Dick, M. B., Kesslak, J. P., & Cotman, C. W. (1994) · Neurobiology of Aging · doi:10.1016/0197-4580(94)00055-7 · Cited by 54
Morgan, E. L., Sanderson, S., Scholz, W. W., Noonan, D. J., Weigle, W. O., & Hugli, T. E. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.12.3937 · Cited by 51
Human astrocytes express membrane cofactor protein (CD46), a regulator of complement activation
Gordon, D., Sadlon, T. A., Wesselingh, S. L., Russell, S. M., Johnstone, R. W., & Purcell, D. F. J. (1992) · Journal of Neuroimmunology · doi:10.1016/0165-5728(92)90051-l · Cited by 46
Maat-Schieman, M. L. C., Rozemuller, A. J., van Duinen, S. G., Haan, J., Eikelenboom, P., & Roos, R. A. C. (1994) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199409000-00007 · Cited by 44
Self-citationKalaria, R. N., & Kroon, S. N. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)80830-7 · Cited by 42
Activated microglia and cerebral amyloid deposits in alzheimer's disease
Rozemüller, A. J. M., van der Valk, P., & Eikelenboom, P. (1992) · Research in Immunology · doi:10.1016/0923-2494(92)80050-u · Cited by 42
Self-citationEikelenboom, P., Hack, C. E., Kamphorst, W., & Rozemuller, J. M. (1992) · Research in Immunology · doi:10.1016/0923-2494(92)80044-l · Cited by 40
Self-citationImmunology and Alzheimer’s Disease
(1988) · Springer eBooks · doi:10.1007/978-3-642-46634-2 · Cited by 39
Yang, C., Jones, J. L., & Barnum, S. R. (1993) · Journal of Neuroimmunology · doi:10.1016/0165-5728(93)90022-q · Cited by 37
Nerl, C., Mayeux, R. P., & O'Neill, G. J. (1984) · Neurology · doi:10.1212/wnl.34.3.310 · Cited by 36
Complement C1q Does Not Bind Monomeric β-Amyloid
Snyder, S. W., Wang, G. T., Barrett, L., Ladror, U. S., Casuto, D., Lee, C. M., Krafft, G. A., Holzman, R. B., & Holzman, T. F. (1994) · Experimental Neurology · doi:10.1006/exnr.1994.1121 · Cited by 34
Rozemüller, A. J. M., Bots, G. T. A. M., Roos, R. A. C., & Eikelenboom, P. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90087-n · Cited by 27
Self-citationComplement C4 Phenotypes in Dementia of the Alzheimer Type
Eikelenboom, P., Goetz, J., Pronk, J. C., & Hauptmann, G. (1988) · Human Heredity · doi:10.1159/000153754 · Cited by 26
Self-citationImmunological Markers and Neuropathological Lesions in Alzheimer’s Disease
Pouplard-Barthelaix, A. (1988) · Springer eBooks · doi:10.1007/978-3-642-46634-2_2 · Cited by 25
Functional aspects of the C1q receptors.
Tenner, A. J. (1993) · PubMed · Cited by 25
New Immunological Findings in Senile Dementia1
POUPLARD, A., & Emile, J. (2015) · Interdisciplinary topics in gerontology and geriatrics · doi:10.1159/000410597 · Cited by 23
Veerhuis, R., van Es, L. A., & Daha, M. R. (1985) · European Journal of Immunology · doi:10.1002/eji.1830150904 · Cited by 22
Self-citationNon-Neuronal Cells in Alzheimer's Disease
Zatta, P. F., & Nicolini, M. (1995) · WORLD SCIENTIFIC eBooks · doi:10.1142/2596 · Cited by 18
C3 and haptoglobin polymorphism in dementia of the Alzheimer type
Eikelenboom, P., Vink‐Starreveld, M. L., Jansen, W., & Pronk, J. C. (1984) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1984.tb02478.x · Cited by 13
Self-citationC1-inhibitor: structure/function and biologic role.
Aulak, K. S., Donaldson, V. H., Coutinho, M., & Davis, A. E. (1993) · PubMed · Cited by 7
The Blood-Brain Barrier in Cerebral Amyloidogenesis in Alzheimer’s Disease and Scrapie
Eikelenboom, P., Fraser, H., Rozemüller, A. J. M., & Stam, F. C. (1988) · Springer eBooks · doi:10.1007/978-3-642-46634-2_4 · Cited by 5
Self-citationProteins of the brain and cerebrospinal fluid in health and disease
Paterson, P. Y. (1984) · Journal of Neuroimmunology · doi:10.1016/0165-5728(84)90045-6 · Cited by 4
Role of Inflammation and Complement Activation in Alzheimer's Disease
Veerhuis, R., Zhan, S., & Eikelenboom, P. (1995) · WORLD SCIENTIFIC eBooks · doi:10.1142/9789812831354_0014 · Cited by 4
Self-citationComplement allotypes in familial and sporadic alzheimer's disease
Panegyres, P. K., & Dawkins, R. L. (1991) · Journal of Neurology · doi:10.1007/bf00315331 · Cited by 3
Research works printed but not linked: 3
- Mehne, 1976, Ein serogenetische Beitrag zur ätiopathogenese der Alzheimerischen Erkrankung, Akt. Geront., 6, 259
- Veerhuis, 1995, Immunolocalization of receptors for the globular and collagen region of the complement component C1q in Alzheimer disease brain, Soc. Neurosci. Abstr., 21, 147
- Zhan, 1994, Immunohistochemical distribution of the inhibitors of the terminal complement complex in Alzheimer's disease, Neurodegeneration, 3, 111
Cited by
Oxidative stress in brain agingImplications for therapeutics of neurodegenerative diseases
FLOYD, R., & HENSLEY, K. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00019-2 · Cited by 830
Inflammatory processes in Alzheimer's disease
Heneka, M. T., & O'Banion, M. K. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.11.017 · Cited by 782
“This in vitro finding is consistent with the immunohistochemical data in AD brains showing weak or absent immunostaining for early complement components in diffuse plaques composed of non- or low-grade fibrillar Aβ (Eikelenboom and Veerhuis, 1996).”
Neuroinflammation: The role and consequences
Lyman, M., Lloyd, D. G., Ji, X., Vizcaychipi, M. P., & Ma, D. (2014) · Neuroscience Research · doi:10.1016/j.neures.2013.10.004 · Cited by 730
Vascular risk factors for Alzheimer’s disease:
Breteler, M. M. B. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(99)00110-4 · Cited by 664
Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP/PS1 mice
Shi, Q., Chowdhury, S., Ma, R., Le, K. X., Hong, S., Caldarone, B. J., Stevens, B., & Lemere, C. A. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf6295 · Cited by 593
Metadata
- Authors
- Eikelenboom, P., & Veerhuis, R.
- Affiliations
- Vrije Universiteit Amsterdam (NL)
- Corresponding author
- Eikelenboom, P.
- Venue
- Neurobiology of Aging
- Publisher
- Elsevier BV
- Published
- 1996-09
- Volume
- 17
- Issue
- 5
- Pages
- 673-680
- ISSN
- 0197-4580 (ISSN-L)
- OpenAlex
- W2026303819
- Cited by
- 206
- References
- 100
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 3 · 2023: 5 · 2022: 5 · 2021: 4 · 2020: 4 · 2019: 3 · 2018: 6 · 2017: 2 · 2016: 2 · 2015: 4 · 2014: 7 · 2013: 9 · 2012: 9
- FWCI
- 7.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Neurobiology of Aging (publishedVersion)
- PubMed (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, complement system, activated microglia, amyloid-beta, neuritic plaques, complement activation products, membrane attack complex, neuroinflammation, neurotoxicity, amyloid hypothesis, protease inhibitors, cytokines
- MeSH terms
- Alzheimer Disease, Brain, Complement System Proteins, Humans, Inflammation, Macrophage Activation, Microglia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.